Small but specialized A tight team (11-50 employees) operating highly specialized urology and cancer treatment services indicates potential for targeted partnerships, preferred vendor programs, and enterprise-focused service add-ons that scale with growth.

Niche clinical platforms Core offerings in ESWL centers, IMRT radiation for prostate cancer, GreenLight HPS for BPH, and cryotherapy present multiple cross-sell opportunities with medical device suppliers, radiology IT vendors, and post-acute care networks seeking integrated urology and oncology solutions.

Tech stack maturity Adoption of iCIMS, Microsoft 365, Windows Server, Google Analytics, and ASP.NET suggests compatibility with common enterprise tools; sales plays can emphasize seamless integrations, security, and compliance services.

Growth signals Revenue in the low to mid single digits with modest funding hints at potential future round opportunities and room for acceleration through partnerships with larger health systems or regional networks seeking scalable specialty services.

Competitive landscape Positioned among prominent hospital systems, there is an opportunity to differentiate via specialized outpatient centers, rapid treatment access, and coordinated care pathways that can appeal to patient referral networks and IDNs seeking focused urology and oncology capabilities.